TherapeuticsMD Inc (NYSE MKT LLC:TXMD)
| 2.63 Data as of May 22 |  -0.08 / -2.95%Today’s Change | 1.25 Today|||52-Week Range 3.70 | -15.16% Year-to-Date |
Latest TXMD News | Press Releases
No recent news for TherapeuticsMD Inc.
Today’s Trading
| Previous close | 2.71 |
| Today’s open | 2.75 |
| Day’s range | 2.55 - 2.84 |
| Volume | 86,855 |
| Average volume (3 months) | 131,848 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 4:02pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +73.91% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +26.00% |
| Revenue growth (last year) | +356.21% |
| P/E ratio | NM |
| Price/Sales | 10.56 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | +1.11 | +9.80% |
| LCILannett Company Inc | -0.12 | -0.99% |
| ENTAEnanta Pharmaceutica... | -0.34 | -1.67% |
| XOMAXOMA Corp | -0.22 | -5.26% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $48.2K |
| Annual profit (last year) | -$955.1K |
| Net profit margin | -1,057.53% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
Chief Executive Officer & Director Robert G. Finizio |
President, Secretary & Director John C. K. Milligan |
Corporate headquarters Boca Raton, Florida |
Forecasts
